Detalhe da pesquisa
1.
Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response.
PLoS Pathog
; 19(5): e1011359, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37256916
2.
HIV-1 infections with multiple founders associate with the development of neutralization breadth.
PLoS Pathog
; 18(3): e1010369, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303045
3.
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses.
PLoS Pathog
; 17(3): e1009386, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651828
4.
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.
Immunity
; 41(6): 909-18, 2014 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25526306
5.
Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization Breadth.
J Virol
; 95(17): e0079721, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34160251
6.
RV144 HIV-1 vaccination impacts post-infection antibody responses.
PLoS Pathog
; 16(12): e1009101, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33290394
7.
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand.
PLoS Pathog
; 16(2): e1008179, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027734
8.
Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2.
Immunity
; 38(1): 176-86, 2013 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23313589
9.
Factors influencing estimates of HIV-1 infection timing using BEAST.
PLoS Comput Biol
; 17(2): e1008537, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33524022
10.
Factors associated with testing for HIV and other sexually transmitted infections in men who have sex with men and transgender women in Bangkok, Thailand.
AIDS Res Ther
; 19(1): 25, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729561
11.
Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency.
J Virol
; 94(4)2020 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776278
12.
Expansion of Stem Cell-Like CD4+ Memory T Cells during Acute HIV-1 Infection Is Linked to Rapid Disease Progression.
J Virol
; 93(14)2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043532
13.
Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection.
PLoS Pathog
; 14(2): e1006888, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29474461
14.
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.
N Engl J Med
; 374(22): 2120-30, 2016 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27192360
15.
Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism.
J Virol
; 92(14)2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29743361
16.
Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.
PLoS Pathog
; 13(2): e1006182, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28235027
17.
Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.
PLoS Pathog
; 13(7): e1006510, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28759651
18.
Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.
PLoS Pathog
; 13(9): e1006620, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28910384
19.
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection.
PLoS Pathog
; 12(8): e1005805, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27486665
20.
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.
Nature
; 490(7420): 417-20, 2012 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22960785